Cargando…
Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma
Acute pulmonary toxicity associated with brentuximab appears to be a rare but serious adverse effect that can be potentially fatal. We report the case of a twenty-nine-year-old female with Hodgkin's lymphoma who was treated with brentuximab and later presented with severe acute pulmonary toxici...
Autores principales: | Sabet, Yasmin, Ramirez, Saul, Rosell Cespedes, Elizabeth, Rensoli Velasquez, Marimer, Porres-Muñoz, Mateo, Gaur, Sumit, Figueroa-Casas, Juan B., Porres-Aguilar, Mateo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852124/ https://www.ncbi.nlm.nih.gov/pubmed/27190667 http://dx.doi.org/10.1155/2016/2359437 |
Ejemplares similares
-
Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
por: Chen, Runzhe, et al.
Publicado: (2015) -
Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions
por: Porres‐Aguilar, Mateo, et al.
Publicado: (2019) -
Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma
por: Wu, Hung-Bo, et al.
Publicado: (2013) -
Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
por: Siddiqi, Tanya, et al.
Publicado: (2014) -
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
por: Salihoglu, A., et al.
Publicado: (2014)